September 6, 2024 — Think about it. Profound change is coming to healthcare and health systems because of the imperative for obesity care at scale. Right now, we are seeing only a faint glimmer of the changes that lie ahead. That’s because the biggest struggles with this change are very basic. Lilly and Novo Nordisk are straining to produce […]
July 18, 2024 — The excitement of the moment we are in for obesity care can make it hard to step back and take a long view. But a new study in the International Journal of Obesity offers a good reminder about the importance of doing just that. Hanna Konttinen and colleagues offer us a good, objective view of […]
May 5, 2024 — “Drug compounding with semaglutide and tirzepatide is a public health emergency,” said a respected obesity medicine physician to us this week. They were right. Most of the compounded drugs people encounter when they are desperate to obtain these life-changing medicines are sketchy at best. This week, FDA announced the arrest of a TikToker for selling […]
April 20, 2021 — Perhaps you know this feeling: muddling, struggling, dragging. Neither depressed nor flourishing. After a year of this pandemic, many people find themselves in this COVID state of mind. In fact, a global study of mental health in the pandemic lockdown by Andrew Gloster et al found that fully half of the people studied had only […]
